Five-Day Fasting-Mimicking Diet Shows Promise for Crohn’s Disease Relief

For many people with Crohn’s disease, diet feels like a missing treatment piece. A new Stanford-led randomized clinical trial suggests a structured, five-day‑a‑month fasting-mimicking diet (FMD) can improve symptoms and gut inflammation in adults with mild-to-moderate disease.[2][4] Kulkarni et al. (2026, Nature Medicine)[4] found this approach can be added to standard medications, not used instead of them.

Unlike long-term restrictive diets, this strategy compresses calorie restriction into short, repeatable cycles.[1][2] It is intensive and not appropriate for everyone, especially those with weight loss or malnutrition.[1][2]

💡 Key takeaway: A short, supervised diet program can influence Crohn’s symptoms and biology—but it is not a do‑it‑yourself cure.

What the five-day fasting-mimicking trial found

The trial enrolled 97 U.S. adults with mild-to-moderate Crohn’s disease.[1][4]

• FMD group: 65 participants followed a five-day, plant-based, low‑calorie plan once a month for three months, returning to usual eating in between.[1][4]
• Control group: 32 participants continued their usual baseline diet.[1][4]
• Both groups: Stayed on their prescribed Crohn’s medications throughout.[2][4]

📊 Clinical response and remission

Primary outcome: clinical response, defined as ≥70‑point drop in CDAI or CDAI ≤150 after the third five-day cycle.[4]

• Clinical response:
  • 69.2% in the FMD group[4]
  • 43.8% in the control group[4]
• Clinical remission (secondary outcome):
  • 64.6% in the FMD group[4]
  • 37.5% in the control group[4]

These findings suggest the five-day intervention often reduced disease activity to low levels.[4]

In practical terms, about two‑thirds of people on FMD reported:

• Less diarrhea, abdominal pain, and cramping by three months[1][2][3][4]
• Noticeable relief for many after just one cycle[1][2][3][4]
• Fewer bowel movements and milder pain by the second month[1][4]

⚠️ Key point: Some control patients also improved, reflecting Crohn’s natural ups and downs and highlighting the need for controlled trials to test diets.[1][4]

How the fasting-mimicking diet works—and what made this trial stand out

A fasting-mimicking diet is a carefully designed, mainly plant-based plan that sharply cuts calories for a few days while still allowing food.[1][2] The aim is to trigger a “fasting-like” metabolic state—altering fuel use and inflammatory signaling—without water-only fasting or extreme, unsupervised restriction.[2][3]

In this trial, participants consumed about 700–1,100 calories per day during each five-day cycle, mostly from plant-based meals.[1][3][4] For the remaining ~25 days, they returned to their usual diets, repeating this monthly for three months.[1][3][4]

📊 Biological changes

Researchers measured objective markers of gut inflammation.[4] Compared with controls, the FMD group showed:

• 22% median decrease in fecal calprotectin (stool marker of intestinal inflammation)[4]
• 8% median increase in fecal calprotectin in the control group[4]
• Decreases in inflammatory lipid mediators and immune-effector gene transcripts[4]

These changes suggest effects on underlying inflammatory pathways, not just symptom perception.[3][4]

This was the largest randomized controlled oral diet trial in adults with Crohn’s disease, in a field long dominated by small or lower-quality diet studies despite high patient interest.[2] Lead investigator Dr. Sidhartha Sinha noted the team was “very pleasantly surprised” that a majority benefited and that some gains appeared after just one cycle.[1][3][4]

💡 Key takeaway: The FMD trial stands out for its size, randomized design, and biological data, shifting diet from speculation toward an evidence-based Crohn’s strategy.[2][4]

Who might benefit, safety concerns, and next steps

The study focused on adults with mild-to-moderate Crohn’s disease.[2][4] It did not target people with:

• Severe disease
• Recent surgery
• Significant malnutrition
• Complications such as strictures or fistulas[2][4]

Aggressive calorie restriction can be risky in Crohn’s, where many already face:[1][2]

• Unintended weight loss
• Poor appetite
• Nutrient deficiencies

Potential harms of FMD include:

• Further weight loss
• Worsening malnutrition
• Dehydration, especially with ongoing diarrhea[1]

⚠️ Key point: FMD was used in addition to, not instead of, biologics or immunosuppressants.[2][4] No participants stopped prescribed treatment; doing so without guidance could trigger severe flares or complications.[1][2]

Anyone considering this approach should work with a gastroenterologist and registered dietitian to:

• Assess suitability and nutritional risks
• Monitor weight, labs, and symptoms
• Set clear stop rules (e.g., rapid weight loss, severe fatigue, worsening pain)

💡 Key takeaway: This diet should only be attempted under professional supervision, especially for people underweight, recently hospitalized, or struggling to meet calorie needs.[1][2]

Conclusion: Promising data, careful use

A five-day‑a‑month fasting-mimicking diet, repeated for three months, produced higher clinical response and remission rates than a usual diet in adults with mild-to-moderate Crohn’s disease, along with reductions in fecal calprotectin and other inflammatory markers.[1][3][4]

At the same time, it is an intensive, calorie-restricted program with real risks if used unsupervised. The trial supports diet as a meaningful adjunct—not a replacement—for standard Crohn’s therapy and points toward a future where structured, evidence-based nutrition plays a clearer role in disease management.[1][2][4]